Results 161 to 170 of about 46,924 (216)

The asymmetric opening of HIV-1 Env by a potent CD4 mimetic enables anti-coreceptor binding site antibodies to mediate ADCC. [PDF]

Nat Commun
Richard J, Grunst MW, Niu L, Díaz-Salinas MA, Zhu L, Tolbert WD, Marchitto L, Zhou F, Bourassa C, Kim H, Boodapati SLT, Yang D, Chiu TJ, Chen HC, Benlarbi M, Beaudoin-Bussières G, Gottumukkala S, Li W, Dionne K, Bélanger É, Chatterjee D, Medjahed H, Hendrickson WA, Sodroski J, Lang ZC, Morton AJ, Huang RK, Matthies D, Smith AB, Kumar P, Mothes W, Munro JB, Pazgier M, Finzi A.   +33 more
europepmc   +1 more source

Evolving rare B cell lineages for an effective HIV vaccine. [PDF]

Science
Permar SR, Wilson PC.
europepmc   +1 more source

HIV subtype-specific gp140-CD4 binding, Temsavir efficacy, and identification of novel adhesion inhibitors against Chinese HIV strains. [PDF]

Front Immunol
Liu T, Li X, Yang X, Zhang S, Wang Y, Zhang S, Cheng L, Tang S, Wang F, Zhao Y, Lu H, Wei L.   +11 more
europepmc   +1 more source

Lactic acid produced by optimal vaginal Lactobacillus spp. potently and specifically inactivates HIV-1 in vitro by targeting the viral RNA genome and reverse transcriptase. [PDF]

PLoS Pathog
Aldunate M, Tyssen D, Johnson A, Latham CF, Ellenberg P, Cowieson N, Hayward JA, Center RJ, Ramsland PA, Hearps AC, Tachedjian G.   +10 more
europepmc   +1 more source

Correction: Reduced Fc-mediated antibody responses after COVID-19 mRNA vaccination in a cohort of people living with HIV-1. [PDF]

Sci Rep
Klingler J, Rao PG, Bandres JC, Pena I, Roldan KB, Singh G, Monahan B, Gleason C, Chen Y, Slamanig S, Sun W, Upadhyay C, Hioe CE.   +12 more
europepmc   +1 more source

Viral glycoprotein-mediated entry and antibody-mediated immunity in HIV-1 and SARS-CoV-2 infection. [PDF]

Front Immunol
Grunst MW, Li W, Mothes W.
europepmc   +1 more source

Design of a highly potent bifunctional HIV-1 entry inhibitor targeting both gp120 and gp41. [PDF]

RSC Med Chem
Du X, Li Q, Du S, Wang H, Shi A, Yuan M, Yu F, Liu Y, Wang C.   +8 more
europepmc   +1 more source

Crystal structure of HERV-K envelope glycoprotein surface subunit

Nikolopoulos N, Modis Y.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

GP120: Biologic Aspects of Structural Features

Annual Review of Immunology, 2001
▪ Abstract  HIV-1 particles are decorated with a network of densely arranged envelope spikes on their surface. Each spike is formed of a trimer of heterodimers of the gp120 surface and the gp41 transmembrane glycoproteins. These molecules mediate HIV-1 entry into target cells, initiating the HIV-1 replication cycle.
Pascal Poignard, Erica Ollmann Saphire, Dennis R Burton   +2 more
exaly   +3 more sources